STOCK TITAN

Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Lantheus Holdings (NASDAQ: LNTH), a leading radiopharmaceutical company, announced that CEO Brian Markison will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025. The presentation is scheduled for Tuesday, June 10, at 2:40 p.m. ET. Investors and interested parties can access the live webcast through the Investors section of Lantheus's website at www.lantheus.com. A replay of the presentation will remain available on the company's website for a minimum of 30 days after the live event.
Lantheus Holdings (NASDAQ: LNTH), un'azienda leader nel settore dei radiofarmaci, ha annunciato che il CEO Brian Markison parteciperà alla 46ª Conferenza Globale Annuale sulla Sanità 2025 organizzata da Goldman Sachs. La presentazione è prevista per martedì 10 giugno alle 14:40 ET. Investitori e interessati potranno seguire la diretta streaming nella sezione Investitori del sito web di Lantheus all'indirizzo www.lantheus.com. La registrazione della presentazione sarà disponibile sul sito dell'azienda per almeno 30 giorni dopo l'evento dal vivo.
Lantheus Holdings (NASDAQ: LNTH), una empresa líder en radiofármacos, anunció que el CEO Brian Markison presentará en la 46ª Conferencia Global Anual de Salud 2025 de Goldman Sachs. La presentación está programada para el martes 10 de junio a las 2:40 p.m. ET. Inversionistas e interesados podrán acceder a la transmisión en vivo a través de la sección de Inversionistas en el sitio web de Lantheus en www.lantheus.com. La repetición de la presentación estará disponible en el sitio web de la empresa por un mínimo de 30 días después del evento en vivo.
라네테우스 홀딩스(NASDAQ: LNTH), 선도적인 방사성 의약품 회사가 CEO 브라이언 마키슨이 2025년 골드만 삭스 제46회 연례 글로벌 헬스케어 컨퍼런스에서 발표할 예정이라고 발표했습니다. 발표는 6월 10일 화요일 오후 2시 40분(동부 시간)에 예정되어 있습니다. 투자자 및 관심 있는 분들은 www.lantheus.com의 투자자 섹션을 통해 생중계 웹캐스트에 접속할 수 있습니다. 발표 녹화는 라이브 이벤트 후 최소 30일 동안 회사 웹사이트에서 다시보기로 제공됩니다.
Lantheus Holdings (NASDAQ : LNTH), une entreprise leader dans le domaine des radiopharmaceutiques, a annoncé que son PDG Brian Markison présentera lors de la 46e Conférence mondiale annuelle sur la santé 2025 de Goldman Sachs. La présentation est prévue pour le mardi 10 juin à 14h40 (heure de l'Est). Les investisseurs et parties intéressées pourront accéder à la diffusion en direct via la section Investisseurs du site web de Lantheus à l'adresse www.lantheus.com. Un replay de la présentation restera disponible sur le site de la société pendant au moins 30 jours après l'événement en direct.
Lantheus Holdings (NASDAQ: LNTH), ein führendes Radiopharmaunternehmen, gab bekannt, dass CEO Brian Markison auf der 46. jährlichen globalen Gesundheitskonferenz 2025 von Goldman Sachs auftreten wird. Die Präsentation ist für Dienstag, den 10. Juni, um 14:40 Uhr ET geplant. Investoren und Interessierte können den Live-Webcast über den Investor-Bereich der Lantheus-Website unter www.lantheus.com verfolgen. Eine Aufzeichnung der Präsentation wird mindestens 30 Tage nach der Live-Veranstaltung auf der Unternehmenswebsite verfügbar sein.
Positive
  • None.
Negative
  • None.

BEDFORD, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Brian Markison, Chief Executive Officer, will present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 at 2:40 p.m. ET on Tuesday, June 10.

To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.

About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. For more information, visit www.lantheus.com.

Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com

Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com


FAQ

When is Lantheus (LNTH) presenting at the Goldman Sachs Healthcare Conference 2025?

Lantheus will present at the Goldman Sachs Healthcare Conference on Tuesday, June 10, 2025, at 2:40 p.m. ET.

How can investors access Lantheus's (LNTH) presentation at the Goldman Sachs conference?

Investors can access the live webcast through the Investors section of Lantheus's website at www.lantheus.com.

Who will represent Lantheus (LNTH) at the Goldman Sachs Healthcare Conference 2025?

Brian Markison, Chief Executive Officer of Lantheus, will present at the conference.

How long will the replay of Lantheus's (LNTH) Goldman Sachs conference presentation be available?

The presentation replay will be available on Lantheus's website for at least 30 days following the live presentation.
Lantheus Holding

NASDAQ:LNTH

LNTH Rankings

LNTH Latest News

LNTH Stock Data

5.13B
67.56M
2.74%
111.94%
9.26%
Drug Manufacturers - Specialty & Generic
In Vitro & in Vivo Diagnostic Substances
Link
United States
NORTH BILLERICA